Industrial Pharmacy Advisory Group (IPAG)

Experts in Industrial Pharmacy

RPS Industrial Pharmacy Advisory Group (IPAG) provides a source of expertise on issues of pharmacy practice which impact on patients, the public, and the profession.

IPAG is a consultative group to the Boards of the RPS, acting as a source of expertise and advice, and providing evidenced-based leadership and opinion to inform RPS policy decisions and advice to government and other organisations.

The main aim of IPAG is to provide leadership in practice, identify and track the changing healthcare environment, advise on the implications for the industrial sector and the RPS and also highlight the changing professional needs and competencies of its members.

Read the Terms of Reference for the Industrial Pharmacy Advisory Group (IPAG).


Sunayana Shah (Chair)

  • Neel Bhatt
  • Ciara O'Brien
  • Jeremy Clarke
  • Vito Constanza
  • Diar Fattah
  • Sarah Goffin
  • Sue Kilby
  • Yetunde Kolade
  • Stephen Makin
  • Jane Nicholson
  • Kendall Pitt
  • Robert Smith
  • Rebecca Stanbrook
  • Pratik Thakkar  

The EIPG newsletter

Read the official newsletter of the European Industrial Pharmacists' Group.

  • Read the March 2024 newsletter
    The March newsletter has updates on how AI is changing the Pharma Industry and the role of the Industrial Pharmacist, about generative AI in drug development, plus environmental sustainability: the EIPG perspective.
  • Read the January 2024 newsletter
    In January's newsletter, we have updates on the drug shortage situation, about the ICMRA collaborative hybrid inspection pilot, and the European Council’s recommendations on R&I.
  • Read the September 2023 newsletter
    In September's newsletter, we have news about Bureau Elections and EU Pharma Legislation seminar in the EU Parliament, a report from the Industrial Forum on the EU deployment of advanced manufacturing technologies, an EMA paper reflecting on AI in the pharmaceutical lifecycle, and a look at how the UK will participate in European research programmes.
  • Read the February 2023 newsletter
    In this February issue, you'll find news about The Windsor Framework, a Review of the pharmaceutical legislation, the proposals of the industrial associations, an EMA/EFSA joint report on human dietary exposure to residues of veterinary medicines, pesticides and feed additives, and HERA reports on stockpiling of antimicrobials.